Axitinib CAS No. 319460-85-0 Pharmaceutical Intermediates

- High Efficacy: Axitinib is a potent tyrosine kinase inhibitor specifically designed for the treatment of advanced renal cell carcinoma (RCC).

- Targeted Action: This drug selectively inhibits vascular endothelial growth factor receptors (VEGFR), effectively blocking tumor growth and angiogenesis.

- Quality Assurance: Manufactured under stringent quality control standards, ensuring high purity and reliability for pharmaceutical applications.

- Global Trade Expertise: As a foreign trade company, we provide timely delivery and compliance with international quality standards.

- Comprehensive Support: Our dedicated team offers expert guidance and support to meet your pharmaceutical needs.

product details

Product details

Product detail

Axitinib is an innovative oral medication that serves as a targeted therapy for advanced renal cell carcinoma (RCC). As a selective inhibitor of vascular endothelial growth factor receptors (VEGFR), Axitinib plays a crucial role in disrupting the signaling pathways that promote tumor growth and blood vessel formation. This makes it an essential therapeutic agent for oncologists and healthcare providers focused on improving patient outcomes in cancer treatment.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Advantages

Utilizing Axitinib in pharmaceutical applications offers several advantages:

1. High Efficacy in Cancer Treatment: Axitinib has demonstrated significant efficacy in clinical trials for patients with advanced RCC, providing a vital treatment option for this challenging disease.

2. Targeted Mechanism of Action: By selectively inhibiting VEGFR, Axitinib effectively disrupts the tumor's blood supply, leading to reduced tumor growth and improved patient outcomes.

3. Compatibility with Laboratory Instruments: Axitinib is designed to be compatible with large-scale laboratory instruments, making it an essential consumable for researchers and pharmaceutical manufacturers.

4. Global Availability: As a foreign trade company, we have established a robust supply chain that allows us to deliver our products globally, ensuring timely and efficient service.

5. Expert Guidance and Support: Our knowledgeable team is dedicated to providing exceptional customer service, offering expert advice and support to help you make informed decisions regarding your pharmaceutical needs.

Physical and Chemical Properties

Axitinib possesses distinct physical and chemical properties that contribute to its effectiveness as an anticancer agent:

- Molecular Formula: The molecular formula of Axitinib is C22H18N4OS, reflecting its complex structure that is essential for its biological activity.

- Molecular Weight: The molecular weight of Axitinib is approximately 386.47 g/mol, which is important for dosage calculations and formulations in pharmaceutical settings.

- Appearance: Axitinib is typically presented as a white to off-white crystalline powder, making it easy to handle and incorporate into various formulations.

- Solubility: The compound is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, allowing for flexibility in laboratory applications.

- Stability: Axitinib exhibits good stability under standard laboratory conditions, making it suitable for long-term storage and use in synthesis processes.

In summary

In conclusion, Ziprasidone HCl rich in (S)-3-amino-3-phenylpropionic acid is an important component in the treatment of psychiatric disorders. Our commitment to quality, integrated manufacturing processes and customer-centric approach make us a trusted partner in the pharmaceutical industry. We invite you to explore our products and experience the superior quality and service we provide.